{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:12:54Z","timestamp":1789668774902,"version":"4.0.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.semarthrit.2026.152979","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T07:42:48Z","timestamp":1775720568000},"page":"152979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systemic sclerosis-related digital ulcers: Current understanding and updated management approaches- a primer for clinicians"],"prefix":"10.1016","volume":"78","author":[{"given":"Gulsen","family":"Ozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn T","family":"Domsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.semarthrit.2026.152979_bib0001","first-page":"1369","article-title":"Systemic sclerosis: one year in review 2025","volume":"43","author":"Di Battista","year":"2025","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0002","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/acr.20336","article-title":"Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry","volume":"63","author":"Khimdas","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152979_bib0003","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s10067-025-07449-1","article-title":"Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology","volume":"44","author":"Orlandi","year":"2025","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0004","article-title":"Registry evaluation of digital ulcers in systemic sclerosis","volume":"2010","author":"Galluccio","year":"2010","journal-title":"Int J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152979_bib0005","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152979_bib0006","doi-asserted-by":"crossref","first-page":"510","DOI":"10.12968\/jowc.2014.23.10.510","article-title":"Scleroderma and evidence based non-pharmaceutical treatment modalities for digital ulcers: a systematic review","volume":"23","author":"Moran","year":"2014","journal-title":"J Wound Care"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152979_bib0007","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/acr.24127","article-title":"Multicenter qualitative study exploring the patient experience of digital ulcers in systemic sclerosis","volume":"72","author":"Hughes","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152979_bib0008","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/acr.24902","article-title":"Health care utilization in systemic sclerosis patients with digital ulcers","volume":"75","author":"Nevskaya","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/keu296","article-title":"Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis","volume":"54","author":"Bruni","year":"2015","journal-title":"Rheumatol (Oxford)"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152979_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5301\/jsrd.5000236","article-title":"Defining skin ulcers in Systemic Sclerosis: systematic Literature Review and proposed World Scleroderma Foundation (WSF) definition","volume":"2","author":"Suliman","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152979_bib0011","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/2397198318764796","article-title":"Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: a challenge for clinical trial design","volume":"3","author":"Hughes","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152979_bib0012","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.24333","article-title":"Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis","volume":"60","author":"Herrick","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152979_bib0013","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/acr.22833","article-title":"Does the clinical context improve the reliability of rheumatologists grading digital ulcers in systemic sclerosis?","volume":"68","author":"Hughes","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152979_bib0014","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152979_bib0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/annrheumdis-2014-207001","article-title":"Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study","volume":"75","author":"Hachulla","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.semarthrit.2026.152979_bib0016","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.2016.5258","article-title":"Effect of Macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials","volume":"315","author":"Khanna","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152979_bib0017","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","article-title":"Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial","volume":"70","author":"Matucci-Cerinic","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152979_bib0019","first-page":"1407","article-title":"Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis","volume":"19","author":"Wigley","year":"1992","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152979_bib0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamadermatol.2021.1463","article-title":"A practical approach to the management of digital ulcers in patients with systemic sclerosis: a narrative review","volume":"157","author":"Hughes","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152220","article-title":"Domain reporting in systemic sclerosis-related digital ulcers: an OMERACT scoping review","volume":"61","author":"Hughes","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0022","unstructured":"Hughes M., Pauling J.D. Optimising the assessment and novel mechanistic insights into digital ulcers in systemic sclerosis: the international \u2018100 DU\u2019 study: scleroderma Clinical Trials Consortium, 2024."},{"key":"10.1016\/j.semarthrit.2026.152979_bib0023","first-page":"105","article-title":"Vascular involvement in systemic sclerosis (scleroderma)","volume":"4","author":"Pattanaik","year":"2011","journal-title":"J Inflamm Res"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152979_bib0024","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/09537104.2012.719090","article-title":"The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis","volume":"24","author":"Pauling","year":"2013","journal-title":"Platelets"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152979_bib0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005792-198011000-00001","article-title":"Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon","volume":"59","author":"Rodnan","year":"1980","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0026","first-page":"102","article-title":"Ulnar artery involvement in systemic sclerosis (scleroderma)","volume":"29","author":"Taylor","year":"2002","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152979_bib0027","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1016\/S2665-9913(23)00189-3","article-title":"MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study","volume":"5","author":"Hughes","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152979_bib0028","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/03009742.2013.780095","article-title":"A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact","volume":"42","author":"Ennis","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152979_bib0029","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.2008.09004.x","article-title":"Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors","volume":"160","author":"Sunderkotter","year":"2009","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152979_bib0030","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3899\/jrheum.081044","article-title":"Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinerAIR-Sclerodermie)","volume":"36","author":"Tiev","year":"2009","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152979_bib0031","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 91","key":"10.1016\/j.semarthrit.2026.152979_bib0032","first-page":"S47","article-title":"An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database","volume":"33","author":"Brand","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152979_bib0033","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/annrheumdis-2015-207271","article-title":"Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database","volume":"75","author":"Wirz","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152979_bib0034","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1093\/rheumatology\/keaf290","article-title":"Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort","volume":"64","author":"Di Donato","year":"2025","journal-title":"Rheumatol (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152979_bib0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","article-title":"Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions","volume":"49","author":"Amanzi","year":"2010","journal-title":"Rheumatol (Oxford)"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152979_bib0036","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/annrheumdis-2015-208121","article-title":"Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry","volume":"75","author":"Matucci-Cerinic","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152979_bib0037","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00296-021-04983-4","article-title":"Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study","volume":"42","author":"Caetano","year":"2022","journal-title":"Rheumatol Int"},{"issue":"Suppl 131","key":"10.1016\/j.semarthrit.2026.152979_bib0038","doi-asserted-by":"crossref","first-page":"43","DOI":"10.55563\/clinexprheumatol\/9ivp9g","article-title":"Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA","volume":"39","author":"Sankar","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152979_bib0039","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2014.10.009","article-title":"A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patients","volume":"14","author":"Silva","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152979_bib0040","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/annrheumdis-2011-200631","article-title":"Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry","volume":"71","author":"Denton","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0041","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/23971983221118720","article-title":"Prevalence of and factors independently associated with digital ischemic complications in patients with systemic sclerosis","volume":"8","author":"Guayboon","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152979_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001012","article-title":"Association of antiphospholipid antibodies with active digital ulceration in systemic sclerosis","volume":"5","author":"Martin","year":"2019","journal-title":"RMD Open"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152979_bib0043","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1007\/s10067-020-05141-0","article-title":"Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients","volume":"39","author":"Rosato","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152810","article-title":"Dual positivity for Anti-Ro52 and Anti-Ro60 antibodies is linked to greater organ involvement and disease progression in systemic sclerosis","volume":"74","author":"Yin","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152979_bib0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/kem190","article-title":"Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity","volume":"46","author":"Caramaschi","year":"2007","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0046","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/annrheumdis-2011-200022","article-title":"Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study","volume":"71","author":"Sebastiani","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0047","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/ard.2010.132431","article-title":"Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions","volume":"70","author":"Smith","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152979_bib0048","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","article-title":"Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study","volume":"68","author":"Cutolo","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2026.152979_bib0049","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/rheumatology\/keaa514","article-title":"Laser speckle contrast analysis predicts major vascular complications and mortality of patients with systemic sclerosis","volume":"60","author":"Gigante","year":"2021","journal-title":"Rheumatol (Oxford)"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152979_bib0050","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3899\/jrheum.151412","article-title":"Thermographic abnormalities are associated with future digital ulcers and death in patients with systemic sclerosis","volume":"43","author":"Hughes","year":"2016","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152979_bib0051","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/annrheumdis-2011-200143","article-title":"Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis","volume":"71","author":"Avouac","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152979_bib0052","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.semarthrit.2021.02.008","article-title":"Ultrasonographic imaging of systemic sclerosis digital ulcers: a systematic literature review and validation steps","volume":"51","author":"Suliman","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152979_bib0053","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/rheumatology\/keae371","article-title":"Development of a measuring app for systemic sclerosis-related digital ulceration (SALVE: scleroderma App for Lesion VErification)","volume":"63","author":"Davison","year":"2024","journal-title":"Rheumatol (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2026.152979_bib0054","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S2665-9913(19)30164-X","article-title":"Digital ulcers: should debridement be a standard of care in systemic sclerosis?","volume":"2","author":"Hughes","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2026.152979_bib0055","first-page":"S1","article-title":"Wound bed preparation: a systematic approach to wound management","volume":"11","author":"Schultz","year":"2003","journal-title":"Wound Repair Regen"},{"issue":"11","key":"10.1016\/j.semarthrit.2026.152979_bib0056","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","article-title":"Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatol (Oxford)"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152979_bib0057","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acr.20673","article-title":"Scleroderma digital ulcers complicated by infection with fecal pathogens","volume":"64","author":"Giuggioli","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0058","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251352340","article-title":"Pharmacological management of pain in digital ulcers of systemic sclerosis: a PRISMA-driven systematic review","author":"Almeida","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0059","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251339821","article-title":"Recommendations for the local management of digital ulcers in systemic sclerosis: a report from the World Scleroderma Foundation (WSF) 'Ad hoc committee","author":"Campochiaro","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-023-06796-1","article-title":"The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study","volume":"43","author":"Ross","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2026.152979_bib0061","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/ard.2009.116475","article-title":"Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study","volume":"69","author":"Brueckner","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152979_bib0062","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1093\/rheumatology\/keab147","article-title":"A clinical comparison of an endothelin receptor antagonist and phosphodiesterase type 5 inhibitors for treating digital ulcers of systemic sclerosis","volume":"60","author":"Chang","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.semarthrit.2026.152979_bib0063","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/rheumatology\/keq291","article-title":"Efficacy of tadalafil in secondary Raynaud's phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial","volume":"49","author":"Shenoy","year":"2010","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0064","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251340559","article-title":"Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: results from the World Scleroderma Foundation Ad Hoc Committee","author":"Maltez","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0065","article-title":"Iloprost duration for digital ulcers in systemic sclerosis: french retrospective study at two centers and literature review","volume":"9","author":"Jamart","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0066","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5301\/jsrd.5000232","article-title":"Digital ulcers in SSc treated with oral treprostinil: a randomized, double-blind, placebo-controlled study with open-label follow-up","volume":"2","author":"Seibold","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152979_bib0067","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3899\/jrheum.151437","article-title":"The recurrence of digital ulcers in patients with systemic sclerosis after discontinuation of oral treprostinil","volume":"43","author":"Shah","year":"2016","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2026.152979_bib0068","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1093\/rheumatology\/keaf292","article-title":"Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study","volume":"64","author":"Iannone","year":"2025","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0069","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13075-019-1979-7","article-title":"A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers","volume":"21","author":"Nagaraja","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.semarthrit.2026.152979_bib0070","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s10067-025-07433-9","article-title":"BAricitinib in patients with SystemIC Sclerosis (BASICS): a prospective, open-label, randomised trial","volume":"44","author":"Chen","year":"2025","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2026.152979_bib0071","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/art.40358","article-title":"Belimumab for the treatment of early diffuse systemic sclerosis: results of a randomized, double-blind, placebo-controlled, pilot trial","volume":"70","author":"Gordon","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"26","key":"10.1016\/j.semarthrit.2026.152979_bib0072","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-Associated Interstitial Lung Disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semarthrit.2026.152979_bib0073","first-page":"1801","article-title":"Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers","volume":"35","author":"Abou-Raya","year":"2008","journal-title":"J Rheumatol"},{"issue":"SI","key":"10.1016\/j.semarthrit.2026.152979_bib0074","doi-asserted-by":"crossref","first-page":"SI91","DOI":"10.1093\/rheumatology\/keac405","article-title":"Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model","volume":"62","author":"Garaiman","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0075","doi-asserted-by":"crossref","DOI":"10.1177\/23971983251348059","article-title":"Hand surgical and injectable treatments in systemic sclerosis: a systematic review of published cases","author":"Perrier","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152979_bib0076","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.42342","article-title":"Efficacy and safety of botulinum toxin in adults with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, randomized, double-blind, placebo-controlled study","volume":"75","author":"Senet","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0077","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-018-1792-8","article-title":"Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study","volume":"21","author":"Del Papa","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0078","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/23971983221116669","article-title":"Percutaneous revascularization for the treatment of refractory digital ischemia in systemic sclerosis","volume":"8","author":"Romero-Karam","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"10.1016\/j.semarthrit.2026.152979_bib0079","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/rheumatology\/keae130","article-title":"Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis","volume":"64","author":"Bandini","year":"2025","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-019-1822-1","article-title":"Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher\/European Scleroderma Trials and Research group (EUSTAR) survey","volume":"21","author":"Blagojevic","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2026.152979_bib0081","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13075-019-2087-4","article-title":"Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU(R)) patient-reported outcome instrument","volume":"22","author":"Mouthon","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 100","key":"10.1016\/j.semarthrit.2026.152979_bib0082","first-page":"142","article-title":"Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis","volume":"34","author":"Ahrens","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152979_bib0083","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3899\/jrheum.171486","article-title":"Preliminary validation of the digital ulcer clinical assessment score in systemic sclerosis","volume":"46","author":"Bruni","year":"2019","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152979_bib0084","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2026.152979_bib0085","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/rheumatology\/ket019","article-title":"Efficacy of ambrisentan in the treatment of digital ulcers in patients with systemic sclerosis: a preliminary study","volume":"52","author":"Parisi","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.semarthrit.2026.152979_bib0086","article-title":"A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: study design and rationale of the VITALISScE study","author":"Khanna","year":"2024","journal-title":"J Scleroderma Relat Disord"},{"issue":"20","key":"10.1016\/j.semarthrit.2026.152979_bib0087","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa2415160","article-title":"Sotatercept in patients with pulmonary arterial hypertension at high risk for death","volume":"392","author":"Humbert","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:59:18Z","timestamp":1789667958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":87,"alternative-id":["S0049017226000685"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152979","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis-related digital ulcers: Current understanding and updated management approaches- a primer for clinicians","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.152979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152979"}}